News Search Results
Jul 15, 2025, 08:00 ET Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jul 15, 2025, 07:30 ET Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Jul 15, 2025, 07:00 ET Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
BOSTON, July 15, 2025 /PRNewswire/ -- Tract Bio, a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced the appointment of Chris
More news about: Tract Bio
Jul 14, 2025, 19:00 ET Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
semaglutide (0.5 mg, once-weekly) via SQ injection. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Jul 14, 2025, 17:31 ET MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight
Palatin Technologies, Inc., Aldeyra Therapeutics, Inc., ReGenTree, RegeneRx Biopharmaceuticals, Inc., Mimetogen, Alcon, Aerie Pharmaceuticals, BRIM Biotechnology, Inc., Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis, S.A., PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll BioPharma
More news about: DelveInsight Business Research, LLP
Jul 14, 2025, 14:50 ET LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jul 14, 2025, 14:37 ET LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations. With modern operations and strategic alliances with world-leading laboratories, LabConnect
More news about: LabConnect
Jul 14, 2025, 13:03 ET Kalorama Information's 2025 IVD Atlas Tracks Global Growth Hotspots, Led by China and Emerging Markets
Information has been a trusted publisher of healthcare market research for over 25 years. Its analysts specialize in in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests,
More news about: Kalorama Information
Jul 14, 2025, 12:52 ET Perfume Ingredient Chemicals Market to Reach USD 11.43 Billion by 2032, Reports Credence Research
suppliers including BASF and Sensient support mass-market production with essential aroma compounds. The market is increasingly shaped by innovation in biotechnology, growing regulatory compliance, and rising demand for natural, allergen-free formulations, driving collaboration across all competitive tiers.
More news about: Credence Research Inc.
Jul 14, 2025, 11:30 ET Geotechnical Construction Services Market Size US$3.83 billion by 2031, Experiences Growth Due to Increased Infrastructure Development Across the Globe | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 14, 2025, 11:15 ET Battery Energy Storage System Market Size US$143.28 billion by 2031, Experiences Growing Focus on Establishing Vigorous Storage Infrastructure | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
More news about: The Insight Partners
Jul 14, 2025, 11:00 ET Anesthesia Monitoring Devices Market Size expected to reach US$5.93 billion by 2031| The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 14, 2025, 08:28 ET Egret Therapeutics Appoints Dr. Geoffrey Ling to Scientific Advisory Board - Advancing its Mission to Address Critical Military Health Needs
Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following acute injuries NEW YORK,
More news about: Turret Capital Management
Jul 14, 2025, 08:15 ET ZINZINO AB (PUBL.): ZINZINO INITIATES NEGOTIATIONS FOR PART OWNERSHIP IN ANDORRA-BASED XION INTERNATIONAL GROUP FOR FURTHER DEVELOPMENT OF PROPRIETARY OMEGA-3 OIL AND SPIRULINA
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales. Xion is an innovative, proprietary production company based in
More news about: Zinzino
Jul 14, 2025, 08:05 ET FITCI and McBee Moore & Vanik IP, LLC form "Power Partnership"
firm based in Frederick, MD, and Tysons Corner, VA, specializes in chemistry, biotechnology, materials science, medical technology, and pharmaceuticals. Their expertise aligns seamlessly with FITCI's mission as a nonprofit to cultivate
More news about: FITCI
Jul 14, 2025, 08:00 ET ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
XenoTherapeutics, Inc. ("Xeno"), a non-profit biotechnology company, under which Xeno will acquire (the "Transaction") all of the issued and outstanding common shares of ESSA (the "Common Shares"). XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ: XOMA), the biotechnology royalty aggregator, is acting as the
More news about: ESSA Pharma Inc
Jul 14, 2025, 07:00 ET Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative
More news about: Nanoscope Therapeutics
Jul 14, 2025, 03:38 ET Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
worldwide through early R&D collaboration models." About Illimis Therapeutics Illimis Therapeutics is a pioneering biotechnology company at the forefront of developing innovative therapies for challenging central nervous system (CNS) and immune-related diseases. The company's
More news about: Illimis Therapeutics
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
TURKU, Finland, July 14, 2025 /PRNewswire/ -- Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing announces the results of a clinical pilot study published
More news about: Genomill Health
Jul 14, 2025, 02:43 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Jul 14, 2025, 02:07 ET MGI Tech Won Green World Award for Sustainable Contribution to Thai Mangroves Conservation Efforts
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Jul 13, 2025, 22:42 ET Global Times: Readers' Reflections: Building BRICS into a primary channel for strengthening solidarity and cooperation among Global South nations: Egyptian scholar
initiatives like the BRICS Action Plan for Innovation Cooperation can stimulate technological progress, especially in artificial intelligence, biotechnology, and green energy. Collaborations with Chinese and Indian educational institutions can enhance Egypt's workforce
More news about: Global Times
Jul 13, 2025, 20:00 ET CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
On July 3, 2025, a U.S.-based biotechnology — the sole appellant among the original two opponents — formally withdrew its appeal against the EPO Opposition Division's earlier decision to maintain
More news about: CARsgen Therapeutics
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP